PHARMACEUTICAL FORMULATION
This invention relates to a stable pharmaceutical formulation containing olanzapine. The composition comprises olanzapine or a pharmaceutically acceptable salt thereof, and one or more suitable pharmaceutical excipients, wherein the composition is coated with a coating comprising polyvinyl alcohol.
1 . A pharmaceutical composition comprising olanzapine or a pharmaceutically acceptable salt thereof, and one or more suitable pharmaceutical excipients, wherein the composition is coated with a coating comprising polyvinyl alcohol.
2 . A pharmaceutical composition according to claim 1 , wherein the coating further comprises titanium dioxide.
3 . A pharmaceutical composition according to claim 1 or 2 , wherein the coating further comprises talc.
4 . A pharmaceutical composition according to any preceding claim, wherein the coating contains 20 to 80 wt % polyvinyl alcohol based on the total weight of the coating.
5 . A pharmaceutical composition according to claims 2 to 4 , wherein the coating contains 10 to 60 wt % titanium dioxide based on the total weight of the coating.
6 . A pharmaceutical composition according to claims 3 to 5 , wherein the coating contains 5 to 50 wt % talc based on the total weight of the coating.
7 . A pharmaceutical composition according to any preceding claim, wherein the coating contains 20 to 80 wt % polyvinyl alcohol, 10 to 60 wt % titanium dioxide and 5 to 50 wt % talc based on the total weight of the coating.